Regulation of Transplanted Cell Homing by FGF1 and PDGFB after Doxorubicin Myocardial Injury
There is no effective treatment for the total recovery of myocardial injury caused by an anticancer drug, doxorubicin (Dox). In this study, using a Dox-induced cardiac injury model, we compared the cardioprotective effects of ventricular cells harvested from 11.5-day old embryonic mice (E11.5) with...
Guardado en:
Autores principales: | Mark Baguma-Nibasheka, Tiam Feridooni, Feixiong Zhang, Kishore B.S. Pasumarthi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/405a832b3dc947d2acd71feb9324bc7b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Síndrome de tako-tsubo, caracterización clínica y evolución a un año plazo
por: Ugalde,Héctor, et al.
Publicado: (2017) -
Recurrencia de miocardiopatía por estrés posterior a terremoto en Chile: Reporte de un caso clínico
por: VARELA U,CECILIA, et al.
Publicado: (2011) -
Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction
por: Tian XQ, et al.
Publicado: (2017) -
Assesment of the TEI index of myocardial performance in dogs with doxorubicin-induced cardiomiopathy
por: Sousa,MG, et al.
Publicado: (2014) -
Isoproterenol-Induced Cardiomyopathy Recovery Intervention: Amlexanox and Forskolin Enhances the Resolution of Catecholamine Stress-Induced Maladaptive Myocardial Remodeling
por: Gabriel Komla Adzika, et al.
Publicado: (2021)